Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001
TOKYO–(BUSINESS WIRE)–Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”), a deep tech start-up developing a novel cell therapy, announced... Read more.
KuCoin Labs Announces Its Strategic Partnership with Zoopia, a Platform Dedicated to Bitcoin Ecosystem Staking, to Further Support the Development of BTC Ecosystem
VICTORIA, Seychelles–(BUSINESS WIRE)–#blockchain–KuCoin Labs and Zoopia, an innovative platform dedicated to bitcoin ecosystem staking, have joined... Read more.
BANDAI: “UNION ARENA English version” Announcement Program
Get the latest information and hear the comments from voice actors! The release in North America is set for Oct. 2024! TOKYO–(BUSINESS WIRE)–BANDAI’s... Read more.
Elliptic Labs Deployed on HONOR 90 GT Smartphone
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual... Read more.
NormanMax Gains Lloyd’s Council ‘In Principle’ Approval to Launch Parametric Syndicate 3939 in Partnership with Apollo
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–NormanMax Insurance Holdings, Inc., the US based parametric (re)insurance group, has received ‘approval in principle’... Read more.
Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Illumina, Inc.
NEW YORK–(BUSINESS WIRE)–Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action... Read more.
FPT Hits One Billion USD Revenue in Global IT Services for the First Time
HANOI, Vietnam–(BUSINESS WIRE)–#AI–Global technology corporation FPT has surpassed one billion USD in the global IT services segment, generated... Read more.
Netcapital Announces Pricing of $4 Million Public Offering
BOSTON–(BUSINESS WIRE)–$NCPL #Earnings—Netcapital Inc. (the “Company”) (NASDAQ: NCPL, NPCLW), a digital private capital markets ecosystem,... Read more.
WAINUA™ (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
US FDA approval based on NEURO-TTRansform Phase III results showing WAINUA demonstrated consistent and sustained benefit improving neuropathy impairment and quality... Read more.
Glancy Prongay & Murray LLP Announces Investigation of WillScot Mobile Mini Holdings Corp. (WSC) (f/k/a Double Eagle Acquisition Corp.)
NEW YORK–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) announces its investigation of WillScot Mobile Mini Holdings Corp. (Nasdaq: WSC)... Read more.